Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease-Reference-Cited by-同舟云学术

Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease

Published:2008-11 Issue:11 Volume:38 Page:1122-1129
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:

Author:

Higuchi Nobito,Kato Masaki,Shundo Yuki,Tajiri Hirotaka,Tanaka Masatake,Yamashita Naoki,Kohjima Motoyuki,Kotoh Kazuhiro,Nakamuta Makoto,Takayanagi Ryoichi,Enjoji Munechika

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1872-034X.2008.00382.x/fullpdf

Reference32 articles.

1. Molecular mediators of hepatic steatosis and liver injury;Browning;J Clin Invest,2004

2. Nonalcoholic fatty liver disease;Angulo;N Engl J Med,2002

3. Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease;Nakamuta;Int J Mol Med,2005

4. Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver;Dentin;Biochimie,2005

5. SREBP in signal transduction: cholesterol metabolism and beyond;Bengoechea-Alonso;Curr Opin Cell Biol,2007

Cited by 231 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diabetes as a risk factor for MASH progression;Diabetes Research and Clinical Practice;2024-11

2. Suppression of hepatic ChREBP⍺-CYP2C50 axis-driven fatty acid oxidation sensitizes mice to diet-induced MASLD/MASH;Molecular Metabolism;2024-07

3. Diosmetin as a promising natural therapeutic agent: In vivo, in vitro mechanisms, and clinical studies;Phytotherapy Research;2024-05-15

4. LINC317.5 as a novel biomarker for hypertriglyceridemia in abnormal glucose metabolism;Cell Death Discovery;2024-04-26

5. Essential Oils for the Treatment and Management of Nonalcoholic Fatty Liver Disease (NAFLD);Natural Product Communications;2024-04